Below please find a 13F analysis report for Blue Ridge Capital for Q1 2009. 13F analyses are reports that fund managers with over $100M are required to submit to the SEC, they are publicly available and these reports provide us with some insights on what some hedge fund managers have been investing in.Blue Ridge Capital Management is a $3B+ hedge fund run by John A. Griffin. Griffin is similar to Steve Mandel at Lone Pine Capital and Lee Ainslie at Maverick Capital in that they all are 'Tiger Cubs' (a.k.a. pupils of Julian Robertson while at Tiger Management).
As of the most recent 13F filing completed by Blue Ridge Capital Management their holdings included:
• (AAPL) Apple
• (AMGN) Amgen
• (AMZN) Amazon.com
• (BRK.A) Berkshire Hathaway
• (CVA) Covanta Holding group
• (MA) Master card
• (MIL) Millipore Corp
• (MON) Monsanto Co
• (MSFT) Microsoft
• (NOV) National Oilwell Varco
• (TGT) Target Corporation
• (TMO) Thermo Fisher Scientific
• (V) Visa
• (VALE) Comphania Vale Do Rio Doce
• (VNO) Vornado Realty Trust
The top 5 highest performing equities which Blue Ridge Capital held as of this 13F filing include (AAPL), (VALE), (VNO), (CVA), and(AMZN).
According to AlphaClone data on Blue Ridge Capital Management 27% of their equity portfolio is invested within the technology sector. The total equity value of Blue Ridge Capital's portfolio is $4B+, their total number of reported holdings is 49, and over 52% of the market value of this portfolio is represented within the top 10 holdings.For more information on Blue Ridge Capital Management please see the HedgeFundBlogger.com Hedge Fund Tracker Profile on Blue Ridge by clicking here.
Related to: Blue Ridge Capital Management
Tags:13F analysis Blue Ridge Capital,Blue Ridge capital's holdings, Blue Ridge capital fund, Blue Ridge13F filing, 13F, hedge fund, hedge funds, alternative investments
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.